key: cord-0819756-fy7uispz
authors: Parmar, Malvinder S.
title: TMPRSS2: An Equally Important Protease as ACE2 in the Pathogenicity of SARS-CoV-2 Infection
date: 2021-07-15
journal: Mayo Clin Proc
DOI: 10.1016/j.mayocp.2021.07.005
sha: c86f2c31e7ae374f0c8cb6a3a3a7e6d049ae7e67
doc_id: 819756
cord_uid: fy7uispz

nan

The current pandemic has caused over 135 million infections and over 3 million deaths worldwide. Angiotensin-converting enzyme 2 (ACE2) plays a significant role for the SARS-CoV-2 to gain entry into the host cells and has been recognized since the beginning of the pandemic with over 6000 publications (PubMed as of 9 th April 2021), while the role of Transmembrane protease, serine 2 (TMPRSS2 )-is of equal importance though underrecognized with only 1/5th of the publications (1939).

In the pathogenicity of SARS-CoV-2, in addition to ACE2 and TMPRSS2 other host factors like FURIN and NRP1 are important as well. However, in this perspective we discuss the critical role of TMPRSS2, 1,2 and highlight that both ACE2 and TMPRSS2 are equally important. The co-expression 3 of both ACE2 and TMPRSS2 in the host target cells is important for the SARS-CoV-2 entry into the target cells. It is important to consider strategies to target TMPRSS2 to control the SARS-CoV-2 infection and the pandemic 4 until a safe and effective vaccine against SARS-CoV-2 and its variants becomes available.

All cellular proteins, to sustain life, are subject to a permanent turnover process (apoptosis) that requires de novo synthesis and subsequent degradation. Protein degradation requires proteases to hydrolyze peptide bonds -the bonds that connect amino acids within proteins to make them stable. In 1836, Theodor Schwann introduced the concept of proteolysis and purified an enzyme (later called proteases) pepsin capable of fragmenting peptide bonds. Proteases not only play a substantial role in the hydrolysis of peptide bonds but also reduce the requirement of energy required for such interactions. To date, over 500 proteases, the vast majority are soluble proteins that are active in an aqueous environment within cells, tissues, or body fluids. 150-years later, in 1997, it became evident that proteolysis also occurs within the cell membranes (integral membrane proteins) 5 The details of the structure and functions of the proteases are beyond the scope of this review. Based on the structure and catalytic processes, the proteases are classified, serine, threonine, cysteine, aspartyl, and metalloproteases. Most of the proteases are in solution (soluble) and secreted. However, serine proteases can be membrane-bound through their transmembrane domain and divided into three groups, carboxy-terminal (type I), amino-terminal (type II), and glycosyl-phosphatidylinositol (type III).

The largest group of membrane-bound serine proteases (TTSPs) is type II, with 17 known members subdivided into four phylogenetically distinct subfamilies -matripase, hepsin/transmembrane protease serine (TMPRSS), Corin, and human airway trypsin-like (HAT) proteases. Most of the TTSPs are characterized recently, and their specific physiological role remains unknown. 6 However, appear to play role in digestion, coagulation, iron hemostasis, spermatogenesis, epithelial barrier integrity, fluid balance, hormone processing, wound healing, embryonic development, immune response, inflammation, tumor growth, and metastases. Serine proteases activate through autocatalytic cleavage. 6 Originally Type II transmembrane-bound serine protease (TMPRSS2) was a small intestine-associated protease. 7 It gained interest because of its highly localized expression in the prostate epithelium and its potential role in carcinogenesis, as overexpressed in prostate cancer. However, the function of TMPRSS2 remains unclear as life could be normal in its absence, as the TMPRSS2 (-/-) knockout mouse studies showed normal development, growth, organ function, and survival. 8 Furthermore, in TMPRSS2 knockout mouse, H3N2 influenza strain was found to be avirulent 9 , and a weakened or delayed inflammatory response with SARS-CoV infection. 10 J o u r n a l P r e -p r o o f TMPRSS2 gene is widely conserved and has two isoforms (TMPRSS11A, and TMPRSS11B), both being autocatalytically activated from the inactive zymogen form. 11 It is found at human chromosome 21q22.3 and encodes a protein of 492 amino acids (Figure 1 ). It contains two chains -a noncatalytic chain formed by amino acids 1-255, and the catalytic chain containing remaining amino acids from 256-492. It contains type II transmembrane domain (TM); LDL receptor class A (LDLRA) domain that forms the binding site for calcium; scavenger receptor cysteine-rich (SPCR) domain involved in binding to other cell surfaces; and serine protease domain, with S1 family that cleaves at arginine or lysine residues. Based on its domain structure, it could work as a receptor for specific ligand(s) mediating signals from the environment into the cells. In humans, it' is expressed in the epithelial cells of the nose, trachea, bronchial epithelial cells, digestive tract, prostate. The expression of TMPRSS2 is developmentally regulated and its expression increases with age, 12,13 though androgen-dependent, does not appear to differ in the lungs between men and women. However, highest nasal gene expression is seen in Black individuals compared to Asian, Latino and White individuals. 14 15 The S protein consists of two subunits -S1 (Nterminus), which acts as a receptor-binding region, and S2 (C-terminus), that serves to promote fusion activity or proteolytic priming. 16 As majority of the human coronaviruses, including SARS-CoV-2, exits the producer cells with 'unprimed' S proteins, 17 their entry into the host target cells depends both on the receptor-binding with the membrane-bound angiotensin-converting enzyme 2 (ACE2) and target-cell proteases, mainly TMPRSS2 (Figure 2 ). SARS-CoV-2, like other coronaviruses, after inoculation, enter the target-cells in two steps. First, it binds to cell receptors, the membrane-bound angiotensin-converting enzyme 2(ACE2), followed by S protein priming or cleaving by host cell proteases, 18 and this must occur in a specific sequence. The proteolytic cleavage must occur after ACE2 engagement, because if it occurs before ACE2 binding then these proteases may cleave and inactivate the viral spike. 19 Though several proteases are available but can not retain in the vicinity of ACE2 receptors, 19 and these may inactivate viral spike before ACE2 engagement. Therefore, the location and timing of the activating proteases are important for viral entry into the host target cell and its pathogenicity. TMPRSS2 needs to be anchored in the cell membrane near or coexpressed in the host cells with ACE-2 receptors, and the membrane-bound type II transmembrane serine proteases (TMPRSS2) are pivotal in priming of S protein and entry of the virus into the host target-cell, and its replication and spread. Though SARS-CoV-2 can use other endosomal cysteine proteases -Cathepsin B and L (CatB/L) for priming of S protein but priming by TMPRSS2 is essential. 10 CatB/L activity is dispensable. Co-expression of both ACE2 and TMPRSS2 is paramount for SARS-CoV-2 to enter target cells to cause damage. Furthermore, the expression of TMPRSS2 is developmentally regulated and increases with age, 20 racially modified being highly expressed in Blacks and upregulated in smokers, likely contributing to the severity of infection in the elderly, Black individuals and smokers.

It is important to highlight that TMPRSS2 plays a critical role in priming of the S proteins of most coronaviruses (including SARS-CoV-2), and its inhibition 1 or modification would be an important a therapeutic target for intervention in or prevention of COVID-19, by blocking virus entry into the host target cells. One of the benefits of this approach might be that these proteases are not prone to progressive mutations that viruses do. TMPRSS2 inhibitors -camostat, nafamostat, and aerosolized aprotinin has been shown to attenuate TMPRSS2 activity. There are over 25 ongoing clinical trials of J o u r n a l P r e -p r o o f camostat and 7 of nafamostat around the world for COVID-19 (ClinicalTrials.gov;) . Other agents, like bromhexine (a mucolytic agent), rimantadine, and plasminogen activator inhibitor type 1 (PAI-1) merit evaluation.

SARS-CoV-2 infection, to-date, has caused over 135 million infections and over 3 million deaths worldwide. In addition to the highly virulent virus, various host factors play an important role in its pathogenicity and it is important to recognize and highlight the equal role played by both ACE2 and TMPRSS2 in the pathogenicity of SARS-CoV-2 infection. Most importantly, the co-expression of both ACE2 and TMPRSS2 in the host target cells, so that alternate strategies that target the TMPRSS2 be considered and evaluated in a timely fashion to control the pandemic until a safe and effective vaccine against SARS-CoV-2 and its variants becomes available to the population. . J o u r n a l P r e -p r o o f

SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis

SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes

Targeting TMPRSS2 in SARS-CoV-2 Infection

The discovery of proteases and intramembrane proteolysis (1)

Catalytic cleavage of the androgen-regulated TMPRSS2 protease results in its secretion by prostate and prostate cancer epithelia

Cloning of the TMPRSS2 gene, which encodes a novel serine protease with transmembrane, LDLRA, and SRCR domains and maps to 21q22.3

Phenotypic analysis of mice lacking the Tmprss2-encoded protease

A mutant H3N2 influenza virus uses an alternative activation mechanism in TMPRSS2 knockout mice by loss of an oligosaccharide in the hemagglutinin stalk region

TMPRSS2 Contributes to Virus Spread and Immunopathology in the Airways of Murine Models after Coronavirus Infection

Gene of the month: TMPRSS2 (transmembrane serine protease 2)

Age-related expression of SARS-CoV-2 priming protease TMPRSS2 in the developing lung

Receptor, ACE2, and TMPRSS2 Is Lower in Children Than Adults and Increases with Smoking and COPD

Racial/Ethnic Variation in Nasal Gene Expression of Transmembrane Serine Protease 2 (TMPRSS2)

The M, E, and N structural proteins of the severe acute respiratory syndrome coronavirus are required for efficient assembly, trafficking, and release of virus-like particles

Mechanisms of coronavirus cell entry mediated by the viral spike protein

Potent neutralization of severe acute respiratory syndrome (SARS) coronavirus by a human mAb to S1 protein that blocks receptor association

Protease-dependent virus tropism and pathogenicity

Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection

Age-determined expression of priming protease TMPRSS2 and localization of SARS-CoV-2 in lung epithelium